Passage Bio

Our team spent a meaningful day volunteering at Broad Street Love, coming together to support those in need right here in the heart of Philadelphia. Giving back is more than just a responsibility—it’s part of who we are as a company. Volunteering is a chance for us to strengthen the communities where we live and work, and we're proud to play a role in making Philadelphia an even better place to call home.

This #WorldMentalHealthDay, we’re reminded of how important it is to prioritize our well-being. At Passage Bio, this belief is central to our mission of transforming the lives of people affected by neurodegenerative diseases. When we take care of ourselves, we’re better equipped to care for those who need us most.

Recently, our team had the opportunity to sponsor and participate in the AFTD "Driving Hope" golf tournament. We are honored to support AFTD’s crucial mission to enhance the quality of life for individuals impacted by FTD and drive research toward a cure.

This month, Passage Bio is participating in the Dementia Society of America’s #OperationKeepsafeChallenge—a 60-mile journey aimed at supporting individuals and families affected by dementia. We’re excited to kick off this challenge as a team! Learn more about #OperationKeepsafe and how you can get involved: https://loom.ly/NKM5A8c

As we continute to celebrate #WorldFTDAwareness Week, we’re happy to share that AFTD recently spoke with our Vice President of Clinical Development, Dr. Juan Chavez, about our efforts to develop a therapy for frontotemporal dementia. Dr. Chavez discusses the promising advancements in today’s research landscape and the vital role the #FTD community plays in driving therapeutic development. Learn more at the blog post here: https://loom.ly/R1h3Ybg #endFTD

This week, we had the privilege of welcoming Liz to our Philadelphia office, where she courageously shared her journey as a care partner to her mother who was diagnosed with #FTD. Her powerful story served as a poignant reminder of how critical it is to raise awareness about this often misunderstood and misdiagnosed disease. As we honor #FTDAwarenessWeek, we invite you to learn more about the most common form of dementia for people under 60: https://loom.ly/YR2UD8w We’re in this together. #endFTD

We’re proud to be participating in Chardan's 8th Annual Genetic Medicines Conference next week. Stay tuned for insights and updates from our leadership team as we continue to drive innovation in neurodegenerative conditions. Register to join our presentation here: https://loom.ly/mm9FmVM

This #WorldFTDAwarenessWeek, we’re not just raising awareness—we’re taking action. At Passage Bio, we’re deeply committed to advancing a promising treatment for frontotemporal dementia, and our ongoing clinical trial is a critical step toward making a real difference. Discover how we’re working to change lives: https://loom.ly/N9zzZxM #endFTD

Our employees recently gathered to celebrate our latest victories with an afternoon of bowling, ping pong, pool, and quality time with colleagues. As our CEO put it, "It's about celebrating the journey," and we made sure to do just that. Here's to the exciting milestones ahead!

We're excited to share positive data from Cohort 1 of our upliFT-D trial for #FTD-GRN patients, where #PBFT02 demonstrated robust and durable increases in CSF PRGN expression, maintained for up to a year. You can find more details at #ISFTD24 this week—visit Poster 007 if you're attending, or view the poster here: https://loom.ly/8Iwdvu8